Inactivated viruses will be sourced and incorporated into a line of full process controls under Microbiologics’ Helix Elite molecular standards brand, as well as instrument-specific quality control sets.
Using NanoString’s nCounter analysis system as a platform, the partners aim to jointly discover and validate biomarker signatures for immuno-oncology and targeted therapeutics.
A library and methods expansion for the MALDI Biotyper CA system enables identification of more than 98% of the typical bacterial identification workflow of clinical microbiology laboratories.
A positive-displacement pipette minimizes the time and effort required to maintain precision during repeat dispensing tasks.
HardyChrom Vibrio is a highly selective culture medium for use in primary screening, isolation, and differentiation of Vibrio pathogens.
Royal Philips and Mount Sinai Health System are partnering to develop a digital image repository of patient tissue samples and data analytics.
Lab informatics are essential for enabling labs to determine whether they are running in a cost-effective, optimized way, from a resource standpoint, and from a reagent and contracting standpoint.
In clinical labs, the application of modern lab informatics systems covers a growing range of uses.
Reshaping and broadening the future of lab testing, these diagnostic advances are particularly noteworthy for laboratorians as well as for physicians and patients.
Featured products include an unsaturated iron binding capacity assay from Sekisui Diagnostics, the scalable Labdaq laboratory information system from CompuGroup Medical US, and a high-purity intrinsic factor protein from BBI Solutions.
The portable AQ VOC has the ability to measure close to 400 volatile organic compounds.
Designed to isolate and trap biological and chemical vapors, Safestore vented chemical storage cabinets help prevent cross contamination, chemical release, and operator exposure.
Partners vRad and Xifin encourage physician collaboration in order to facilitate consolidated diagnostic reports of radiology, pathology, and clinical laboratory results.
An alternative to traditional screening methods, the LungFusion panel identifies expressed translocations of known clinical relevance in formalin-fixed, paraffin-embedded and fresh frozen tissue samples.
Featured chemistry and integrated analyzers include the Arkray Aution Hybrid AU-4050 analyzer system from US Arkray Inc, the Advia Chemistry XPT system from Siemens Healthcare, and the Cobas 8000 analyzer series from Roche Diagnostics.
A finely tuned set of orders for intravenous insulin infusions in hospitalized diabetic patients, the Portland Diabetes Protocols have been successfully used at institutions throughout the world to control hyperglycemia.
In critical care settings, tight glucose control is not just for diabetics.
CLP spoke with Roger D. Klein, MD, JD, FCAP, medical director for molecular oncology at the Cleveland Clinic, and chair of the Association for Molecular Pathology’s professional relations committee, to find out more about AMP’s revised policy on direct-to-consumer genetic testing.
In addition to determining health and disease status among individual patients, clinical laboratory testing is playing an increasingly important role in improving broader understandings of disease on a population level.
A line of lyophilized controls is designed to simulate human serum samples for determining linearity, calibration verification, and verification of reportable range on Roche analyzers.